Merck

Recombivax Hb

Manufacturer:

Merck

Recombivax Hb HCPCS:

90743

HCPCS Code Descriptor:

Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use

Category:

CPT Drug Code

Recombivax Hb NDCs:

00006-4995-41, 00006-4094-02

Primary Type:

Vaccine-Hepatitis B

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00006-4094-02, 00006-4995-41

About Recombivax Hb:

Recombivax Hb is a Vaccine-Hepatitis B drug manufactured by Merck and administered via the Intramuscular route of administration. The CPT Drug Code: 90743 is aligned to the drug Recombivax Hb.

ACCESS PRICING AND MORE BY REGISTERING

90743 Added Date:

NA

90743 Effective Date:

NA

90743 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Recombivax Hb billing and coding information.
Recombivax Hb patient assistance information can be found through the Merck Helps Program at the URL: http://www.merckhelps.com/
Recombivax Hb prescribing information can be found at the link below:
Information regarding Recombivax Hb’s side effects can be found at MedlinePlus